Immature granulocyte and other hematological inflammatory parameters in patients with migraine headache

Abstract views: 159 / PDF downloads: 100


  • İdris Kocatürk
  • Sedat Gülten



Migraine, hematological parameters, immature granulocyte, inflammatory pathogenesis


Background: Today, many hypotheses have been proposed in the pathogenesis of migraine. The inflammatory hypothesis is one of them. The immature granulocyte count (IGC) is also an inflammatory parameter which importance has been understood recently. There are no studies evaluating IGC in migraine. The aim of the study to investigate the levels of IGC and other hematological inflammatory parameters in migraine.

Material and Method: Materials and Methods: Forty-eight patients diagnosed with migraine who applied to Kastamonu Training and Research Hospital Neurology outpatient clinic between 07.01.2020 and 10.01.2021 were included in the study. 42 people with similar age and gender distribution were included for the control group. Data on laboratory tests, age and gender of patients were obtained from the hospital Laboratory Information System (LIS). CBC parameters of the patients at the first admission and before any treatment, calculated with an automated hematological analyzer (XN-1000-Hematology-analyzer-Sysmex Corporation, Japan) were analyzed. Using Complete Blood Count (CBC) data, neutrophil count (NEUT#), neutrophil percentage (NEUT%), lymphocyte percentage (LYMPH%), and IGC were recorded. Neutrophil lymphocyte ratio (NLR), platelet lymphocyte ratio (PLR), and systemic immune inflammation index (SII) values were calculated with the formula.

Results: In our study, NLR and IGC was significantly higher than the healthy control group (p=0.002, p=0.025). PLR was also found to be high, but it was not statistically significant (p=0.063).

Conclusion: The significantly higher NLR and IGC levels in migraine patients compared to the healthy controls support the role of inflammation in etiopathogenesis.


Arulmozhi D, Veeranjaneyulu A, Bodhankar S. Migraine: current concepts and emerging therapies. Vasc Pharmacol 2005; 43: 176–87.

Lipton RB, Bigal ME, Diamond M, et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 2007; 68: 343–9.

Steiner TJ, Stovner LJ, Vos T. GBD 2015: migraine is the third cause of disability in under 50s. J Headache Pain 2016; 17: 104.

Uluslararası Baş Ağrısı Derneği’nin (IHS) Baş Ağrısı Sınıflandırma Komitesi. Baş ağrısı bozukluklarının uluslararası sınıflandırması, 3. baskı (beta versiyonu). Sefalalji 2013; 33: 629-808.

Kelman L, Tanış D. Migren ağrısı ve diğer ilişkili semptomlar arasındaki ilişki. Cephalalji 2006; 26: 548–53.

Waeber C, Moskowitz MA. Migraine as an inflammatory disorder. Neurology 2005; 64: 9–15.

Peroutka SJ. Neurogenic inflammation and migraine: implications for the therapeutics. Mol Interv 2005; 5: 304–11.

Fusco M, D’Andrea G, Micciche F, Stecca A, Bernardini D, Cananzi AL. Neurogenic inflammation in primary headaches. Neurol Sci 2003; 24: 61–4.

Perini F, D’andrea G, Galloni E, et al. Plasma cytokine levels in migraineurs and controls. Headache 2005; 45: 926–31.

Sarchielli P, Alberti A, Baldi A, et al. Proinflammatory cytokines, adhesion molecules, and lymphocyte integrin expression in the internal jugular blood of migraine patients without aura assessed ictally. Headache 2006; 46: 200-7.

Tanik N, Celikbilek A, Metin A, Gocmen AY, Inan LE. Retinol-binding protein-4 and hs-CRP levels in patients with migraine. Neurol Sci 2015; 36: 1823–7.

Wang F, He Q, Ren Z, et al. Association of serum levels of intercellular adhesion molecule-1 and interleukin-6 with migraine. Neurol Sci 2015; 36: 535–40.

Yazar HO, Yazar T, Aygün A, Kaygisiz Ş. Evaluation of simple inflammatory blood parameters in patients with migraine. Irish J Med Sci (1971 -) 2020; 189: 677–83.

Uzar E, Evliyaoglu O, Yucel Y, et al. Serum cytokine and pro-brain natriuretic peptide (BNP) levels in patients with migraine. Eur Rev Med Pharmacol Sci 2011; 15: 1111–6.

Güzel I, Taşdemir N, Çelik Y. Evaluation of serum transforming growth factor β1 and C-reactive protein levels in migraine patients. Neurol Neurochir Pol 2013; 47: 357–362.

Welch K, Brandes AW, Salerno L, Brandes JL. C-reactive protein may be increased in migraine patients who present with complex clinical features. Headache 2006; 46: 197–9.

Yılmaz U. A New and early marker in the diagnosis of acute complicated appendicitis: immature granulocytes.Ulus Travma Acil Cerrahi Derg 2018; 24: 434-9.

Mare TA, Treacher DF, ShankarHari M, et al. The diagnostic and prognostic significance of monitoring blood levels of immature neutrophils in patients with systemic inflammation. Crit Care 2015; 19: 57.

Karon BS, Tolan NV, Wockenfus AM, et al. Evaluation of lactate, white blood cell count, neutrophil count, procalcitonin and immature granulocyte count as biomarkers for sepsis in emergency department patients Clin Biochem 2017; 50: 956-8.

Gudmundsson LS, Aspelund T, Scher AI, et al. C-reactive protein in migraine sufferers similar to that of non-migraineurs: the Reykjavik Study. Cephalalgia 2009; 29: 1301–10.

Fidan I, Yüksel S, Ýmir T, İrkeç C, Aksakal FN. The importance of cytokines, chemokines and nitric oxide in pathophysiology of migraine. J Neuroimmunol 2006; 171: 184–8.

Tanure MTA, Gomez RS, Hurtado RCL, Teixeira AL, Domingues RB. Increased serum levels of brain-derived neurotropic factor during migraine attacks: a pilot study. J Headache Pain 2010; 11: 427–30.

Charles A. The pathophysiology of migraine: implications for clinical management. Lancet Neurol 2018; 17: 174–82.

Özge A, Buğdaycı R, Şaşmaz T, et al. The sensitivity and specificity of the case definition criteria in Mersin. Cephalalgia 2002; 22: 791–8.

Huang WJ, Zhang X, Chen WW. Role of oxidative stress in Alzheimer disease. Biomed Rep 2016; 4: 519–22.

Cai Z, He W, Zhuang FJ, Chen Y. The role of high high-sensitivity C-reactive protein levels at admission on poor prognosis after acute ischemic stroke. Int J Neurosci 2019; 129: 423–9.

Yazar T, Yazar HO. Evalution of C-reactive protein/albumin ratio according to stage in patients with idiopathic Parkinson disease. Turk J Neurol 2019; 25: 123–8.

Akıl E, Bulut A, Kaplan İ, Özdemir HH, Arslan D, Aluçlu MU. The increase of carcinoembryonic antigen (CEA), high-sensitivity C-reactive protein, and neutrophil/lymphocyte ratio in Parkinson’s disease. Neurol Sci 2015; 36: 423–8.

Ozdemir HH. Analysis of the albumin level, neutrophil-lymphocyte ratio, and platelet-lymphocyte ratio in Guillain-Barré syndrome. ArqNeuropsiquiatr 2016; 74: 718–22.

Park MG, Kim MK, Chae SH, Kim HK, Han J, Park KP. Lymphocyte-to-monocyte ratio on day 7 is associated with outcomes in acute ischemic stroke. Neurol Sci 2018; 39: 243–9.

Freedman JE, Loscalzo J. Platelet–monocyte aggregates: bridging thrombosis and inflammation. Circulation 2002; 105: 2130–2.

Zeller JA, Lindner V, Frahm K, Baron R, Deuschl G. Platelet activation and plateletleucocyte interaction in patients with migraine Subtype differences and influence of triptans. Cephalalgia 2005; 25: 536–41.

Marin Hernandez C, Pinero Madrona A, Gil Vazquez PJ, Galindo Fernandez PJ, Ruiz Merino G, Alonso Romero JL. Usefulness of lymphocyte-to-monocyte, neutrophil-to-monocyte and neutrophil-to-lymphocyte ratios as prognostic markers in breast cancer patients treated with neoadjuvant chemotherapy. Clin Transl Oncol 2018; 20: 476–83.

Balta S, Demırer Z, Aparci M, Yildirim AO, Ozturk C. The lymphocyte-monocyte ratio in clinical practice. J Clin Pathol 2015; 69: 88–9.

De Jager CP, van Wijk PT, Mathoera RB. Lymphocytopenia and neutrophil-lymphocyte count ratio predict bacteremia better than conventional infection markers in an emergency care unit. Crit Care 2010; 14: R192.

Zahorec R. Ratio of neutrophil to lymphocyte counts–rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy 2001; 102: 5–14.

Karabulut KU, Egercioglu TU, Uyar M, Ucar Y. The change of neutrophils/ lymphocytes ratio in migraine attacks: a case-controlled study. Ann Med Surg (Lond) 2016; 10: 52–6.

Nierhaus A, Klatte S, Linssen J, et al. Revisiting the white blood cell count: immature granulocytes count as a diagnostic marker to discriminate between SIRS and sepsis – a prospective, observational study. BMC Immunol 2013; 14: 8.

Karakulak S, Narcı H, Ayrık C, Erdogan S, Ucbilek E. The prognostic value of immature granulocyte in patients with acute pancreatitis.Am J EmergMed 2020; S0735-6757(20)30170-4.




How to Cite

Kocatürk, İdris, & Gülten, S. (2021). Immature granulocyte and other hematological inflammatory parameters in patients with migraine headache. Kastamonu Medical Journal, 1(4), 101–104.

Most read articles by the same author(s)